ACHIEVE LIFE SCIENCES, INC. — Director's Dealing 2009

Jan 5, 2009

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ONCOGENEX PHARMACEUTICALS, INC. (OGXI)
CIK: 0000949858
Period of Report: 2008-12-31

Reporting Person: Cormack Scott Daniel (Director, President and CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2008-12-31	stock option (right to buy)	$3.00	A	100000	Acquired	2015-12-31	Common Stock (100000)	Direct

Footnotes

F1: 25,000 shares are exercisable on each of Dec. 31, 2009, 2010, 2011 and 2012.